HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Colfosceril Palmitate

HCID 452110
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
63-89-8
Standard SMILES
CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
Molecular formula
C40H80NO8P
Average molar mass
734 g/mol
Monoisotopic mass
733.56215551

Overview

1,2-dihexadecanoyl-sn-glycero-3-phosphocholine is a phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants. It has a role as a surfactant and a mouse metabolite. It is a phosphatidylcholine 32:0 and a 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphocholine. It is functionally related to a hexadecanoic acid. It is a conjugate base of a 1,2-di-O-palmitoyl-sn-glycero-3-phosphocholine.

Names & identifiers

Preferred name
Colfosceril Palmitate
IUPAC
[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate
English name
1,2-Dipalmitoyl-sn-glycero-3-phosphocholine
Molecular formula
C40H80NO8P
Molecular weight
734.04

Names & synonyms

63-89-8Colfosceril palmitate1,2-Dipalmitoyl-sn-glycero-3-phosphocholinediPalmitoylphosphatidylcholinePalmitate de colfoscerilPalmitato de colfosceriloColfoscerili palmitas1,2-dihexadecanoyl-sn-glycero-3-phosphocholineColfoscerilDppc, l-Dppc, r-Dipalmitoyl lecithin, l-
Show more names
DPPC1,2-dipalmitoyl-sn-glycero-3-PC16:0 PCDIPALMITOYL LECITHINL-A-LECITHIN DIPALMITOYLDIPALMITOYL-L-ALPHA-LECITHINB,G-DIPALMITOYL-L-A-LECITHINL-ALPHA-LECITHIN, DIPALMITOYL
DTXSID5046720129Y83319X2NFW0ADipalmitoyl glycerophosphocholine1-16:0-2-16:0-phosphatidylcholine[(2R)-2,3-di(hexadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphateSURFAXIN COMPONENT DPPCDTXCID3026720

Database identifiers

CAS
63-89-8

Properties

Computed structural properties

XLogP
13.5
Topological polar surface area
111 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
8
Rotatable bonds
40
Heavy atoms
50
Formal charge
0
Complexity
826

Experimental & physicochemical properties

Lipids · 2 items

Lipids -> Unambiguous Lipids

Lipids -> Glycerophospholipids [GP] -> Glycerophosphocholines [GP01] -> Diacylglycerophosphocholines [GP0101]

SolubilityVery poor solubility
Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Boiling Point60.5-61.5ºC at 760 mmHg
Melting Point-63ºC
Physical DescriptionSolid
Collision Cross Section · 2 items

283.9 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Sample Type: Human plasma; Dataset: Unambiguous Lipids]

281.91 Ų [M+H]+ [CCS Type: TIMS; Method: single field calibrated]

Physicochemical properties

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS ClassificationNot Classified

Hazard information

Regulatory InformationColfosceril palmitate: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesNot Classified

Safety data

F
10-21
wgk
3
hs_code
29232000
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
safety_code
24/25
Storage Class
11 - Combustible Solids
Hazard statements
H302-H315-H319-H331-H336-H351-H361d-H372-H412
Precautionary statements
P201-P273-P301+P312+P330-P302+P352-P304+P340+P311-P308+P313

Chemistry & industry

Pharmacology

ATC Code · 2 items

R - Respiratory system

QR - Respiratory system

Protein BindingColfosceril palmitate stays and gets metabolized in the pulmunar tissue, thus it is not able to bind to plasma proteins.
Pharmacodynamics · 1 item

Colfosceril palmitate has shown to significantly reduce the risk of pneumothoraces, pulmonary interstitial emphysema and mortality. Unlike naturals surfactants, colfosceril palmitate reduces the risk of bronchopulmonary dysplasia, intraventricular hemorrhage and patent ductus arteriosus. In clinical placebo-controlled trials, there was a significant reduction in the number of deaths attributed to hyaline membrane disease, the incidence of pulmonary air leaks, oxygen requirements and mean airway pressure. Some reports have indicated a lack of therapeutic effect due to the absence of surfactant protein.

Mechanism of Action · 1 item

Treatment with colfosceril palmitate aims to reinflate a collapsed area of the lung, improve compliance and reduce intrapulmonary shunting. The actions of colfosceril palmitate are perfomed by replacing the defficient or innefective endogenous lung surfactant and thus, reducing the tension and stabilizing the alveoli from collapsing. Colfosceril palmitate will form a very thin film that will cover the surface of the alveolar cells and therefore it will reduce surface tension.

Biological Half-LifeThe half-life of colfosceril palmitate is registered to be in the range of 20-36 hours.
Metabolism/MetabolitesColfosceril palmitate is catabolized and reutilized for further synthesis and secretion in lung tissues.
Absorption, Distribution and Excretion · 4 items

The absorption is done directly in the alveolus into the lung tissue. As the lung surfactant is distributed in the bronchi, bronchioles and alveoli, its highest concentration is at the alveolar air-fluid interface where it remains as a monolayer.

Related reactions

13 records
New reaction record
HRID 37756 reaction equation
HRID 37756As reactant
HRID 230978 reaction equation
HRID 230978As reactant
HRID 230979 reaction equation
HRID 230979As reactant
HRID 230980 reaction equation
HRID 230980As reactant
HRID 399366 reaction equation
HRID 399366As reactant
HRID 481280 reaction equation
HRID 481280As reactant
HRID 1825693 reaction equation
HRID 1825693As reactant
HRID 1865764 reaction equation
HRID 1865764As reactant
PreviousPage 1 of 2

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
PubChem CID
452110
DTXSID
DTXSID5046720
ChEMBL
CHEMBL1200737
ChEBI
CHEBI:72999
UNII
319X2NFW0A
EC Number
200-567-6
Nikkaji
J110.766F
Melting point
229 · 229-229.5 °C
alpha
23 · D23 +6.6° (c = 4.2 in 1:1 chloroform-methanol)
storage temp.
-20 °C · -20°C
solubility
Chloroform (Slightly), Methanol (Slightly)
form
Solid
color
White to Off-White
biological source
synthetic
Merck
14 · 14,2477
Stability
Stable. Incompatible with strong oxidizing agents.
Cosmetics Ingredients Functions
SKIN CONDITIONING
InChIKey
KILNVBDSWZSGLL-KXQOOQHDSA-N
SMILES
[C@@H](OC(=O)CCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCC)COP([O-])(=O)OCC[N+](C)(C)C |&1:0,r|
CAS DataBase Reference
63 · 63-89-8(CAS DataBase Reference)
FDA UNII
319 X2NFW0A · 319X2NFW0A
ATC code
7 AA01 · R07AA01
Comptox DTXSID
5046720 · DTXSID5046720
UNSPSC Code
51191904 · 51191904
NACRES
25 · NA.25
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
302 · H302-H315-H319-H331-H336-H351-H361d-H372-H412
Precautionary statements
201 · P201-P273-P301+P312+P330-P302+P352-P304+P340+P311-P308+P313
Safety Statements
24 · 24/25
WGK Germany
3 · 3
F
10 · 10-21
HS Code
29232000 · 29232000
Storage Class
11 · 11 - Combustible Solids

After 5 days, most of the administered dose (56%) is distributed throughout the body with renal and fecal excretion being the minor elimination pathway representing the 4 and 2% of the eliminated dose respectively. The major route of elimination is by expelled air which accounts for 28% of the administered dose.

Colfosceril palmitate is distributed uniformly to all lobes of the lung, distal airways and alveolar spaces. It will not enter the systemic circulation in healthy lungs, however when the integrity of the tissue is distrupted colfosceril can reach systemic circulation. Even 5 days after administration, there are traces of colfosceril palmitate retained in the body that represented 72% of the administered dose which by then have entered pathways of lipid metabolism to become tissue associated.

After 5 days of drug administration, the lung and liver would contain 10% of the administered dose and the elimination via renal excretion accounts only for 8% of the administered dose. This proved a very small renal clearance and confirmed that the major elimination route is by expired air.

Tissue LocationsPlacenta
Cellular LocationsCytoplasm
Metabolite PathwaysPhosphatidylcholine Biosynthesis PC(16:0/16:0)
Applications · 4 items

DescriptionDPPC, also known as 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine, is a phospholipid containing the 16 carbon fatty acid/palmitic acid (16:0) at the sn-1 and sn-2 positions. It is commonly used in the generation of micelles, liposomes, and other types of artificial membranes. Due to the medium size of fatty acid chain, DLPC is used to form thinner membranes or lipid bilayers.

Uses16:0 PC (DPPC) has been used in the generation of thymoquinone (TQ) liposomes, gold nanorods and calcium chloride encapsulated liposomes and bilayers for biophysical studies.

Uses1,2-dipalmitoyl-sn-glycero-3-phosphocholine is a major phospholipid constituent and primary surface tension lowering component of natural lung surfactant. Colfosceril Palmitate is used as pulmonary surfactant and diagnostic aid (fetal lung maturity).

General Description1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine is a strong bilayer-forming lipid. It the most common phospholipid in mammalian membranes. It is also an important component of the mucosal layer of the colon.

Upstream & downstream products

Upstream raw materials

TYLOXAPOLHexadecanoic acid, 1,1'-[1-[[(2-oxido-1,3,2-dioxaphospholan-2-yl)oxy]methyl]-1,2-ethanediyl] ester[S,(+)]-1-O,2-O-Dipalmitoyl-3-O-trityl-L-glycerol2-Chloroethylphosphoric acid dichlorideCholine glycerophosphate1,2-Dipalmitoyl-sn-glycerolCholine tosylatePalmitic acidTrimethylamine

Downstream products

1,2-Dipalmitoyl-sn-glycero-3-phosphobutanol (sodium salt)
Additional notes · 1 item

DefinitionChEBI: A phosphatidylcholine 32:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl). A synthetic phospholipid used in liposomes and lipid bilayers to study biological membranes. It is also a major constituent of pulmonary surfactants.